Creative Medical Technology Holdings Inc
CELZ2.220USD
+0.050+2.30%
收盘 12/24, 13:00（美东）报价延迟15分钟
5.73M总市值
亏损市盈率 TTM
关于 Creative Medical Technology Holdings Inc 公司
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Creative Medical Technology Holdings Inc简介
公司代码CELZ
公司名称Creative Medical Technology Holdings Inc
上市日期May 01, 2009
CEOWarbington (Timothy)
员工数量4
证券类型Ordinary Share
年结日May 01
公司地址211 E. Osborn Rd.
城市PHOENIX
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编85012
电话14803992822
网址https://creativemedicaltechnology.com/
公司代码CELZ
上市日期May 01, 2009
CEOWarbington (Timothy)
Creative Medical Technology Holdings Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 12月14日 周日
更新时间: 12月14日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
其他
97.16%
持股股东
持股股东
占比
The Vanguard Group, Inc.
0.74%
Geode Capital Management, L.L.C.
0.67%
Creative Medical Health, Inc.
0.65%
DRW Securities, LLC
0.43%
Warbington (Timothy)
0.35%
其他
97.16%
股东类型
持股股东
占比
Investment Advisor
1.37%
Investment Advisor/Hedge Fund
0.67%
Corporation
0.65%
Individual Investor
0.48%
Research Firm
0.03%
其他
96.80%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
27
72.58K
11.84%
--
2025Q3
29
72.58K
11.88%
+776.00
2025Q2
25
71.80K
10.72%
-129.79K
2025Q1
23
201.59K
4.41%
+89.66K
2024Q4
25
29.86K
7.67%
-49.38K
2024Q3
28
77.15K
11.92%
-653.00
2024Q2
30
77.93K
20.77%
-35.91K
2024Q1
32
113.90K
14.79%
-86.68K
2023Q4
34
27.41K
16.84%
+6.21K
2023Q3
38
90.73K
17.10%
+463.00
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
20.88K
0.81%
+2.61K
+14.28%
Jun 30, 2025
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Allworth Financial, L.P.
4.00K
0.15%
+4.00K
--
Jun 30, 2025
Osaic Holdings, Inc.
1.13K
0.04%
-131.00
-10.39%
Jun 30, 2025
Finger (Michael H.)
351.00
0.01%
-1.50K
-81.04%
Apr 15, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
公告日期
类型
比率
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
Jun 09, 2023
Merger
10→1
常见问题
Creative Medical Technology Holdings Inc的前五大股东是谁？
Creative Medical Technology Holdings Inc 的前五大股东如下：
The Vanguard Group, Inc.持有股份：17.63K，占总股份比例：0.68%。
Geode Capital Management, L.L.C.持有股份：20.88K，占总股份比例：0.81%。
Creative Medical Health, Inc.持有股份：22.70K，占总股份比例：0.88%。
Warbington (Timothy)持有股份：12.21K，占总股份比例：0.47%。
Allworth Financial, L.P.持有股份：4.00K，占总股份比例：0.15%。
The Vanguard Group, Inc.持有股份：17.63K，占总股份比例：0.68%。
Geode Capital Management, L.L.C.持有股份：20.88K，占总股份比例：0.81%。
Creative Medical Health, Inc.持有股份：22.70K，占总股份比例：0.88%。
Warbington (Timothy)持有股份：12.21K，占总股份比例：0.47%。
Allworth Financial, L.P.持有股份：4.00K，占总股份比例：0.15%。
Creative Medical Technology Holdings Inc的前三大股东类型是什么？
Creative Medical Technology Holdings Inc 的前三大股东类型分别是：
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Creative Medical Health, Inc.
The Vanguard Group, Inc.
Geode Capital Management, L.L.C.
Creative Medical Health, Inc.
有多少机构持有Creative Medical Technology Holdings Inc(CELZ)的股份？
截至2025Q4，共有27家机构持有Creative Medical Technology Holdings Inc的股份，合计持有的股份价值约为72.58K，占公司总股份的11.84%。与2025Q3相比，机构持股有所增加，增幅为-0.04%。
哪个业务部门对Creative Medical Technology Holdings Inc的收入贡献最大？
在--，--业务部门对Creative Medical Technology Holdings Inc的收入贡献最大，创收--，占总收入的--%。
